Cargando…
PDE5 Inhibitors as Potential Tools in the Treatment of Cystic Fibrosis
Despite great advances in the understanding of the genetics and pathophysiology of cystic fibrosis (CF), there is still no cure for the disease. Using phosphodiesterase type 5 (PDE5) inhibitors, we and others have provided evidence of rescued F508del-CFTR trafficking and corrected deficient chloride...
Autores principales: | Noel, Sabrina, Dhooghe, Barbara, Leal, Teresinha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Research Foundation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3444771/ https://www.ncbi.nlm.nih.gov/pubmed/23024633 http://dx.doi.org/10.3389/fphar.2012.00167 |
Ejemplares similares
-
Correction of Chloride Transport and Mislocalization of CFTR Protein by Vardenafil in the Gastrointestinal Tract of Cystic Fibrosis Mice
por: Dhooghe, Barbara, et al.
Publicado: (2013) -
Resveratrol increases F508del-CFTR dependent salivary secretion in cystic fibrosis mice
por: Dhooghe, Barbara, et al.
Publicado: (2015) -
On the Corner of Models and Cure: Gene Editing in Cystic Fibrosis
por: Ensinck, Marjolein, et al.
Publicado: (2021) -
Type-4 Phosphodiesterase (PDE4) Blockade Reduces NETosis in Cystic Fibrosis
por: Totani, Licia, et al.
Publicado: (2021) -
Cystic fibrosis transmembrane conductance regulator modulators in cystic fibrosis: current perspectives
por: Schmidt, Béla Z, et al.
Publicado: (2016)